Heptares augments business development capabilities in Japan and other Asian Territories

Heptares achieves all research milestones and receives milestone payment from GPCR drug discovery agreement with Takeda

Heptares to present at upcoming scientific and biotech industry conferences

Heptares to present at Boston Biotech BD and Future Leaders in the Biotech Industry Conferences

Heptares StaRs® enable ‘reverse pharmacology’ approach to accelerate GPCR-focused drug discovery

MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting GPCRs

Heptares to moderate panel on rare diseases at BBC New York CEO meeting (13-14 February)

Heptares Partners with Cubist to Research New Medicines Targeting GPCRs